Page last updated: 2024-09-05

sorafenib and benzyloxycarbonylleucyl-leucyl-leucine aldehyde

sorafenib has been researched along with benzyloxycarbonylleucyl-leucyl-leucine aldehyde in 2 studies

Compound Research Comparison

Studies
(sorafenib)
Trials
(sorafenib)
Recent Studies (post-2010)
(sorafenib)
Studies
(benzyloxycarbonylleucyl-leucyl-leucine aldehyde)
Trials
(benzyloxycarbonylleucyl-leucyl-leucine aldehyde)
Recent Studies (post-2010) (benzyloxycarbonylleucyl-leucyl-leucine aldehyde)
6,5207305,2512,47331,057

Protein Interaction Comparison

ProteinTaxonomysorafenib (IC50)benzyloxycarbonylleucyl-leucyl-leucine aldehyde (IC50)
Proteasome subunit beta type-11Homo sapiens (human)1.9893
Calpain-9Homo sapiens (human)9.88
Proteasome subunit alpha type-7Homo sapiens (human)1.9893
Replicase polyprotein 1abSevere acute respiratory syndrome-related coronavirus3.9
Replicase polyprotein 1abSevere acute respiratory syndrome coronavirus 23.8999
AromataseHomo sapiens (human)0.044
Indoleamine 2,3-dioxygenase 1Homo sapiens (human)0.5
Proteasome subunit beta type-1Homo sapiens (human)1.0853
Proteasome subunit alpha type-1Homo sapiens (human)1.9893
Proteasome subunit alpha type-2Homo sapiens (human)1.9893
Proteasome subunit alpha type-3Homo sapiens (human)1.9893
Proteasome subunit alpha type-4Homo sapiens (human)1.9893
Proteasome subunit beta type-8Homo sapiens (human)1.9893
Proteasome subunit beta type-9Homo sapiens (human)1.9893
Proteasome subunit alpha type-5Homo sapiens (human)1.9893
Proteasome subunit beta type-4Homo sapiens (human)1.9893
Proteasome subunit beta type-6Homo sapiens (human)1.9893
Proteasome subunit beta type-5Homo sapiens (human)0.6088
Proteasome subunit beta type-10Homo sapiens (human)1.9893
Proteasome subunit beta type-3Homo sapiens (human)1.9893
Proteasome subunit beta type-2Homo sapiens (human)2.0443
Proteasome subunit alpha type-6Homo sapiens (human)1.9893
Proteasome subunit alpha-type 8Homo sapiens (human)1.9893
Proteasome subunit beta type-7Homo sapiens (human)1.9893

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chao, CC; Kuo, TC; Lu, HP1
Bertolotto, C; Bourcier, C; Grépin, R; Griseri, P; Mazure, N; Pagès, G1

Other Studies

2 other study(ies) available for sorafenib and benzyloxycarbonylleucyl-leucyl-leucine aldehyde

ArticleYear
The tyrosine kinase inhibitor sorafenib sensitizes hepatocellular carcinoma cells to taxol by suppressing the HURP protein.
    Biochemical pharmacology, 2011, Jul-15, Volume: 82, Issue:2

    Topics: Apoptosis; Benzenesulfonates; Carcinoma, Hepatocellular; Cell Line, Tumor; Eukaryotic Initiation Factor-4E; Humans; Leupeptins; Liver Neoplasms; Neoplasm Proteins; NF-kappa B; Niacinamide; Paclitaxel; Phenylurea Compounds; Protein Kinase Inhibitors; Proto-Oncogene Proteins c-rel; Pyridines; Sorafenib

2011
Constitutive ERK activity induces downregulation of tristetraprolin, a major protein controlling interleukin8/CXCL8 mRNA stability in melanoma cells.
    American journal of physiology. Cell physiology, 2011, Volume: 301, Issue:3

    Topics: Animals; Antibodies; Antineoplastic Agents; Apoptosis; Autophagy; Benzamides; Benzenesulfonates; Cell Line, Tumor; Cell Proliferation; Chemokine CXCL1; Chemokine CXCL5; Dichlororibofuranosylbenzimidazole; Down-Regulation; Extracellular Signal-Regulated MAP Kinases; Female; Gene Expression; Genes, Reporter; Half-Life; Humans; Immunotherapy, Active; Interleukin-8; Leupeptins; MAP Kinase Kinase Kinases; Melanoma; Membrane Proteins; Mice; Mice, Inbred BALB C; Microtubule-Associated Proteins; Niacinamide; Phenylurea Compounds; Phosphorylation; Proteasome Endopeptidase Complex; Proteasome Inhibitors; Proto-Oncogene Proteins; Pyridines; Receptors, Interleukin-8B; RNA Stability; RNA, Messenger; RNA, Small Interfering; Sorafenib; Transfection; Tristetraprolin; Tumor Cells, Cultured; Vaccination

2011